The superrich have always been interested in extending their lives, and today's elite are investing money in therapies for life extension. Venki Ramakrishnan's book *Why We Die* explores the biology of aging and potential interventions for extending lifespan. Private equity investments in aging research may distort priorities
2 Comments
Sort: